These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


782 related items for PubMed ID: 25346048

  • 1. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.
    Dige A, Støy S, Thomsen KL, Hvas CL, Agnholt J, Dahlerup JF, Møller HJ, Grønbaek H.
    Scand J Immunol; 2014 Dec; 80(6):417-23. PubMed ID: 25346048
    [Abstract] [Full Text] [Related]

  • 2. Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma.
    Jones K, Vari F, Keane C, Crooks P, Nourse JP, Seymour LA, Gottlieb D, Ritchie D, Gill D, Gandhi MK.
    Clin Cancer Res; 2013 Feb 01; 19(3):731-42. PubMed ID: 23224400
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Divergent effects on macrophage biomarkers soluble CD163 and CD206 in axial spondyloarthritis.
    Heftdal LD, Loft AG, Hendricks O, Ashouri Christiansen A, Schiøttz-Christensen B, Arnbak B, Jurik AG, Østgård R, Winding Deleuran B, Møller HJ, Greisen SR.
    Scand J Clin Lab Invest; 2018 Oct 01; 78(6):483-489. PubMed ID: 30176763
    [Abstract] [Full Text] [Related]

  • 5. Expression of soluble sCD163 in serum of psoriatic patients is modulated by Goeckerman therapy.
    Kondelkova K, Krejsek J, Borska L, Fiala Z, Hamakova K, Andrys C.
    Allergol Immunopathol (Madr); 2013 Oct 01; 41(3):158-62. PubMed ID: 22765877
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease.
    Ogino T, Nishimura J, Barman S, Kayama H, Uematsu S, Okuzaki D, Osawa H, Haraguchi N, Uemura M, Hata T, Takemasa I, Mizushima T, Yamamoto H, Takeda K, Doki Y, Mori M.
    Gastroenterology; 2013 Dec 01; 145(6):1380-91.e1. PubMed ID: 23993972
    [Abstract] [Full Text] [Related]

  • 8. Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels.
    Davis BH, Zarev PV.
    Cytometry B Clin Cytom; 2005 Jan 01; 63(1):16-22. PubMed ID: 15624200
    [Abstract] [Full Text] [Related]

  • 9. Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.
    Andersen MN, Abildgaard N, Maniecki MB, Møller HJ, Andersen NF.
    Eur J Haematol; 2014 Jul 01; 93(1):41-7. PubMed ID: 24612259
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The macrophage-specific serum marker, soluble CD163, is increased in obesity and reduced after dietary-induced weight loss.
    Fjeldborg K, Christiansen T, Bennetzen M, J Møller H, Pedersen SB, Richelsen B.
    Obesity (Silver Spring); 2013 Dec 01; 21(12):2437-43. PubMed ID: 23512476
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue.
    Peng QL, Zhang YL, Shu XM, Yang HB, Zhang L, Chen F, Lu X, Wang GC.
    J Rheumatol; 2015 Jun 01; 42(6):979-87. PubMed ID: 25877505
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Soluble macrophage-derived CD163: a homogenous ectodomain protein with a dissociable haptoglobin-hemoglobin binding.
    Møller HJ, Nielsen MJ, Maniecki MB, Madsen M, Moestrup SK.
    Immunobiology; 2010 May 01; 215(5):406-12. PubMed ID: 19581020
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serum soluble CD163 levels in patients with influenza-associated encephalopathy.
    Hasegawa S, Matsushige T, Inoue H, Takahara M, Kajimoto M, Momonaka H, Ishida C, Tanaka S, Morishima T, Ichiyama T.
    Brain Dev; 2013 Aug 01; 35(7):626-9. PubMed ID: 23149357
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 40.